Ganglioside GM3 Blocks the Activation of Epidermal Growth Factor Receptor Induced by Integrin at Specific Tyrosine Sites
Open accessThe DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Abstract
The epidermal growth factor receptor (EGFR) can be activated by both direct ligand binding and cross-talk with other molecules, such as integrins. This integrin-mediated cross-talk with growth factor receptors participates in regulating cell proliferation, survival, migration, and invasion. Previous studies have shown that ligand-dependent EGFR activation is inhibited by GM3, the predominant ganglioside of epithelial cells, but the effect of GM3 on ligand-independent, integrin-EGFR cross-talk is unknown. Using a squamous carcinoma cell line we show that endogenous accumulation of GM3 disrupts the ligand-independent association of the integrin beta1 subunit with EGFR and results in inhibition of cell proliferation. Consistently, endogenous depletion of GM3 markedly increases the association of EGFR with tyrosine-phosphorylated integrin beta1 and promotes cell proliferation. The ligand-independent stimulation of EGFR does not require focal adhesion kinase phosphorylation or cytoskeletal rearrangement. Stimulation of EGFR and mitogen-activated protein kinase signaling by GM3 depletion involves the phosphorylation of EGFR at tyrosine residues 845, 1068, and 1148 but not 1086 or 1173. The specific blockade of phosphorylation at Tyr-845 with Src family kinase inhibition and at Tyr-1148 with phosphatidylinositol 3-kinase inhibition suggests that GM3 inhibits integrin-induced, ligand-independent EGFR phosphorylation (cross-talk) through suppression of Src family kinase and phosphatidylinositol 3-kinase signaling.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, subtly different forms of the sialylated ganglioside GM3 can have differential effects on tyrosine kinase signaling of the EGF receptor (517 -522)”
From Biological roles of glycans (2017) · cites this paper as [520]
Citations
Cites
1 retracted
Ushio-Fukai, M., Hilenski, L., Santanam, N., Becker, P. L., Ma, Y., Griendling, K. K., & Alexander, R. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105901200 · Cited by 204
RetractedCleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Giancotti, F. G., & Ruoslahti, E. (1999) · Science · doi:10.1126/science.285.5430.1028 · Cited by 3,869
Vlahos, C. J., Matter, W. F., Hui, K. Y., & Brown, R. F. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37680-9 · Cited by 3,240
Integrins and Signal Transduction Pathways: the Road Taken
Clark, E. A., & Brugge, J. S. (1995) · Science · doi:10.1126/science.7716514 · Cited by 2,937
Signaling through focal adhesion kinase
Schlaepfer, D. D., Hauck, C. R., & Sieg, D. J. (1999) · Progress in Biophysics and Molecular Biology · doi:10.1016/s0079-6107(98)00052-2 · Cited by 1,175
Src family kinases are required for integrin but not PDGFR signal transduction
Klinghoffer, R. A., Sachsenmaier, C., Cooper, J. A., & Soriano, P. (1999) · The EMBO Journal · doi:10.1093/emboj/18.9.2459 · Cited by 731
The Adaptor Protein Shc Couples a Class of Integrins to the Control of Cell Cycle Progression
Wary, K. K., Mainiero, F., Isakoff, S. J., Marcantonio, E. E., & Giancotti, F. G. (1996) · Cell · doi:10.1016/s0092-8674(00)81392-6 · Cited by 731
Bremer, E. G., Schlessinger, J., & Hakomori, S. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)35954-9 · Cited by 706
Autophosphorylation sites on the epidermal growth factor receptor
Downward, J., Parker, P., & Waterfield, M. D. (1984) · Nature · doi:10.1038/311483a0 · Cited by 704
Research works printed but not linked: 3
- Satoh, 2001, Int. J. Oncol., 19, 723
- Luttrell, 1988, Mol. Cell. Biol., 8, 497
- Wilson, 1989, Mol. Cell. Biol., 9, 1536
Cited by
Varki, A. (2017) · Glycobiology · doi:10.1093/glycob/cww086 · Cited by 2,635
“For example, subtly different forms of the sialylated ganglioside GM3 can have differential effects on tyrosine kinase signaling of the EGF receptor (517) (518) (519) (520) (521) (522) and elimination of GM3 affects insulin receptor action (405, (523) (524) .”
BackgroundMembrane Domains and the “Lipid Raft” Concept
Sonnino, S., & Prinetti, A. (2012) · Current Medicinal Chemistry · doi:10.2174/09298673130103 · Cited by 214
Randeria, P. S., Seeger, M. A., Wang, X.-Q., Wilson, H., Shipp, D., Mirkin, C. A., & Paller, A. S. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1505951112 · Cited by 224
“In addition to the stimulatory effect of GM3 depletion on insulin receptor/IGF1R activation, our past studies have shown that GM3 inhibits activation of EGFR in normal and neoplastic KCs and that decreased functional GM3 increases EGFR phosphorylation (20).”
BackgroundSelf-citationCaveolin-1 Regulates Matrix Metalloproteinases-1 Induction and CD147/EMMPRIN Cell Surface Clustering
Tang, W., & Hemler, M. E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312947200 · Cited by 154
Glycosphingolipid behaviour in complex membranes
Prinetti, A., Loberto, N., Chigorno, V., & Sonnino, S. (2008) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2008.09.001 · Cited by 152
Dreisewerd, K., Müthing, J., Rohlfing, A., Meisen, I., Vukelić, Ž., Peter‐Katalinić, J., Hillenkamp, F., & Berkenkamp, S. (2005) · Analytical Chemistry · doi:10.1021/ac048373w · Cited by 138
Ueno, S., Saito, S., Wada, T., Yamaguchi, K., Satoh, M., Arai, Y., & Miyagi, T. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m509668200 · Cited by 127
Molecular Recognition of Gangliosides and Their Potential for Cancer Immunotherapies
Krengel, U., & Bousquet, P. A. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00325 · Cited by 124
“The GM3 ganglioside, a wellknown regulator of the insulin receptor (81), has an inhibitory effect on both the EGFR and the VEGFR, while the ganglioside GD1a strongly induces VEGFR-2 activation (26, 66, 70, 75, 82, 83).”
BackgroundAixinjueluo, W., Furukawa, K., Zhang, Q., Hamamura, K., Tokuda, N., Yoshida, S., Ueda, R., & Furukawa, K. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414041200 · Cited by 119
Cellular Functions Regulated by Phosphorylation of EGFR on Tyr845
Sato, K.-I. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140610761 · Cited by 109
“[154] have shown that, in squamous carcinoma cells, SCC12, the depletion of ganglioside GM3, which has been reported”
BackgroundWang, X.-Q., Yan, Q., Sun, P., Liu, J.-W., Go, L., McDaniel, S. M., & Paller, A. S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1300 · Cited by 99
“We have previously shown that GM3 suppresses EGFR tyrosine phosphorylation at Tyr845, Tyr1068, and Tyr1148 (21); consistent with signaling through PKC-a, we now show that GM3 and CD82 enhance EGFR phosphorylation at its Thr654 site.”
InfluentialSelf-citationA crucial role of plasma membrane-associated sialidase in the survival of human cancer cells
Wada, T., Hata, K., Yamaguchi, K., Shiozaki, K., Koseki, K., Moriya, S., & Miyagi, T. (2007) · Oncogene · doi:10.1038/sj.onc.1210341 · Cited by 108
“As expected from the previous reports (Bremer et al., 1986; Wang et al., 2003) describing inhibition of EGFR tyrosine phosphorylation by GM3, siRNA3 introduction reduced phosphorylation of EGFR (Figure 5a, left panel) and in contrast, the overexpression promoted phosphorylation (Figure 5a, right…”
ResultGilmour, A. M., Abdulkhalek, S., Cheng, T. S. W., Alghamdi, F., Jayanth, P., O’Shea, L. K., Geen, O., Arvizu, L. A., & Szewczuk, M. R. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.08.008 · Cited by 89
Plasma Membrane-associated Sialidase as a Crucial Regulator of Transmembrane Signalling
Miyagi, T., Wada, T., Yamaguchi, K., Hata, K., & Shiozaki, K. (2008) · The Journal of Biochemistry · doi:10.1093/jb/mvn089 · Cited by 100
Silencing of GM3 synthase suppresses lung metastasis of murine breast cancer cells
Gu, Y., Zhang, J., Mi, W., Yang, J., Han, F., Lu, X., & Yu, W. (2008) · Breast Cancer Research · doi:10.1186/bcr1841 · Cited by 86
“First, many studies have demonstrated that GM3 gangliosides inhibit phosphorylation of the epidermal growth factor receptor and result in inhibition of PI3K/Akt signaling in varied cell types [48-51].”
BackgroundGanglioside GM3 and its biological functions
Prokazova, N. V., Samovilova, N. N., Gracheva, E. V., & Golovanova, N. K. (2009) · Biochemistry (Moscow) · doi:10.1134/s0006297909030018 · Cited by 95
Kato, K., Shiga, K., Yamaguchi, K., Hata, K., Kobayashi, T., Miyazaki, K., Saijo, S., & Miyagi, T. (2006) · Biochemical Journal · doi:10.1042/bj20050737 · Cited by 81
Jennemann, R., & Gröne, H. (2013) · Progress in Lipid Research · doi:10.1016/j.plipres.2013.02.001 · Cited by 74
Modification of sialylation is associated with multidrug resistance in human acute myeloid leukemia
Ma, H., Zhou, H., Song, X., SHI, S., Zhang, J., & Li, J. (2014) · Oncogene · doi:10.1038/onc.2014.7 · Cited by 71
Gangliosides in Membrane Organization
Sonnino, S., Chiricozzi, E., Grassi, S., Mauri, L., Prioni, S., & Prinetti, A. (2018) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2017.12.007 · Cited by 68
Cretu, A., & Brooks, P. C. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21222 · Cited by 67
“For example, studies have now provided evidence for interactions betweena2b1 and MMP-1, a5b1 and MMP-9, and a3b1 and seprase (Mueller et al., 1999; Dumin et al., 2001; Wang et al., 2003).”
BackgroundGanglioside GM3 and Its Role in Cancer
Zheng, C., Terreni, M., Sollogoub, M., & Zhang, Y. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180129100619 · Cited by 71
Gangliosides as Regulators of Cell Membrane Organization and Functions
Sonnino, S., & Prinetti, A. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-6741-1_12 · Cited by 70
Mukherjee, P., Faber, A. C., Shelton, L. M., Baek, R. C., Chiles, T. C., & Seyfried, T. N. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m800002-jlr200 · Cited by 66
Szewczuk, M. R., O'Shea, L., Abdulkhalek, S., Allison‐Logan, S., & Neufeld, R. J. (2014) · OncoTargets and Therapy · doi:10.2147/ott.s55344 · Cited by 77
Roles of plasma membrane-associated sialidase NEU3 in human cancers
Miyagi, T., Wada, T., & Yamaguchi, K. (2007) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2007.09.016 · Cited by 64
Hayashi, N., Chiba, H., Kuronuma, K., Go, S., Hasegawa, Y., Takahashi, M., Gasa, S., Watanabe, A., Hasegawa, T., Kuroki, Y., et al. (2012) · Cancer Science · doi:10.1111/cas.12027 · Cited by 55
Prinetti, A., Aureli, M., Illuzzi, G., Prioni, S., Nocco, V., Scandroglio, F., Gagliano, N., Tredici, G., Rodriguez‐Menendez, V., Chigorno, V., et al. (2009) · Glycobiology · doi:10.1093/glycob/cwp143 · Cited by 51
Galectins as modulators of receptor tyrosine kinases signaling in health and disease
Porębska, N., Poźniak, M., Matynia, A., Żukowska, D., Zakrzewska, M., Otlewski, J., & Opaliński, Ł. (2021) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2021.03.004 · Cited by 58
Ganglioside GM3 promotes cell migration by regulating MAPK and c-Fos/AP-1
Hashiramoto, A., Mizukami, H., & Yamashita, T. (2006) · Oncogene · doi:10.1038/sj.onc.1209416 · Cited by 50
“Signal transduction through MAPK Previous reports suggested that GM3 might interfere with MAPK signal transduction in numeral types of mammalian cells (Garofalo et al., 2002; Wang et al., 2003).”
BackgroundHuang, X., Li, Y., Zhang, J., Xu, Y., Tian, Y., & Ma, K. (2013) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24503 · Cited by 51
“ganglioside GM3 has the inhibitory activity on cell proliferation, motility, migration, invasiveness, and metastasis in several tumor models [Rebbaa et al., 1996; Kawamura et al., 2001; Noll et al., 2001; Satoh et al., 2001; Wang et al., 2003; Fujimoto et al., 2005].”
BackgroundYamaguchi, K., Hata, K., Wada, T., Moriya, S., & Miyagi, T. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.05.136 · Cited by 46
Sonnino, S., Aureli, M., Loberto, N., Chigorno, V., & Prinetti, A. (2010) · FEBS Letters · doi:10.1016/j.febslet.2009.11.020 · Cited by 44
“pid raft components, including caveolin-1 [21,22] and integrin b1 subunit [23].”
BackgroundHang, Q., Isaji, T., Hou, S., Im, S., Fukuda, T., & Gu, J. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.682229 · Cited by 47
R e‐epithelialization of wounds
Koivisto, L., Häkkinen, L., & Larjava, H. (2011) · Endodontic Topics · doi:10.1111/etp.12007 · Cited by 56
Integrins as “functional hubs” in the regulation of pathological angiogenesis
Contois, L. W., Akalu, A., & Brooks, P. C. (2009) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2009.05.002 · Cited by 50
Wang, X.-Q., Sun, P., & Paller, A. S. (2005) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2005.23669.x · Cited by 39
Self-citationKim, S.-J., Chung, T., Choi, H.-J., Kwak, C.-H., Song, K., Suh, S., Kwon, K., Chang, Y., Park, Y., Chang, H. W., et al. (2012) · Biochemical Journal · doi:10.1042/bj20120189 · Cited by 38
Regulation of EGFR activation and signaling by lipids on the plasma membrane
Kim, D., Triet, H. M., & Ryu, S. H. (2021) · Progress in Lipid Research · doi:10.1016/j.plipres.2021.101115 · Cited by 39
Natoli, T. A., Husson, H., Rogers, K. A., Smith, L. A., Wang, B., Budman, Y., Bukanov, N. O., Ledbetter, S. R., Klinger, K. W., Leonard, J. P., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds172 · Cited by 36
“As a component of lipid rafts, GM3 can interact with cell signaling receptors for growth factors such as the epidermal growth factor (EGF) or insulin (46,47).”
BackgroundLiu, J.-W., Sun, P., Yan, Q., Paller, A. S., Gerami, P., Ho, N. P. S., Vashi, N. A., Poole, I. C. L., & Wang, X.-Q. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1099 · Cited by 34
“GM3 inhibits squamous carcinoma SCC12 cell proliferation through suppressing epidermal growth factor receptor (EGFR) signaling (3, 8).”
BackgroundSelf-citationKansra, S., Stoll, S. W., Johnson, J. L., & Elder, J. T. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.004689 · Cited by 36
“In contrast, Wang et al. (2003) have recently observed complete inhibition of Tyr 845 phosphorylation by 3 M PP1 in skin carcinoma cells stimulated by engagement of 1 integrin by fibronectin.”
BackgroundInhibition of hepatocellular carcinoma growth by blockade of glycosphingolipid synthesis
Jennemann, R., Federico, G., Mathow, D., Rabionet, M., Rampoldi, F., Popović, Z. V., Volz, M., Hielscher, T., Sandhoff, R., & Gröne, H. (2017) · Oncotarget · doi:10.18632/oncotarget.22648 · Cited by 32
“GSLs also participate in signaling events [39]; they concentrate in lipid domains [40] and modify receptor activity of insulin- [41-43], leptin- [44], and epidermal growth factor receptor (EGFR) [45-47].”
BackgroundWang, X.-Q., Sun, P., Go, L., Koti, V., Fliman, M., & Paller, A. S. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700469 · Cited by 30
Self-citationWilken, J. A., Pérez-Torres, M., Nieves-Alicea, R., Cora, E. M., Christensen, T. A., Baron, A. T., & Maihle, N. J. (2013) · Biochemistry · doi:10.1021/bi400437d · Cited by 29
Glycosphingolipid metabolism and polycystic kidney disease
Natoli, T. A., Modur, V., & Ibraghimov‐Beskrovnaya, O. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109526 · Cited by 27
Bianchi, L., Altera, A., Barone, V., Bonente, D., Bacci, T., Benedetto, E. D., Bini, L., Tosi, G. M., Galvagni, F., & Bertelli, E. (2022) · Cells · doi:10.3390/cells11162531 · Cited by 30
“In this respect, cells in iERM express EGFR and EGFR signaling can also occur in the absence of ligands by an integrin-dependent EGFR phosphorylation mechanism requiring the transient formation of an EGFR-β1 integrin macromolecular complex [74,75].”
BackgroundInsights on ErbB glycosylation – contributions to precision oncology
Duarte, H. O., Reis, C. A., & Gomes, J. (2022) · Trends in cancer · doi:10.1016/j.trecan.2022.02.003 · Cited by 21
Li, Y., HUANG, X., Wang, C., Li, Y., Luan, M., & Ma, K. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.3087 · Cited by 19
“It is understood that the phosphorylation and translocation of PLCγ from the cytosol to the plasma membrane are necessary for its activation and function (13).”
BackgroundEfficient Sialylation on Azidododecyl Lactosides by Using B16 Melanoma Cells
Murozuka, Y., Kasuya, M. C. Z., Kobayashi, M., Watanabe, Y., Sato, T., & Hatanaka, K. (2005) · Chemistry & Biodiversity · doi:10.1002/cbdv.200590076 · Cited by 20
Ziulkoski, A. L., Andrade, C. M. B., Crespo, P. M., Sisti, E., Trindade, V. M. T., Daniotti, J. L., Guma, F. T. C. R., & Borojević, R. (2006) · Biochemical Journal · doi:10.1042/bj20051189 · Cited by 20
Role of biologically active sphingolipids in tumor growth
Dyatlovitskaya, E. V., & Kandyba, A. G. (2006) · Biochemistry (Moscow) · doi:10.1134/s0006297906010020 · Cited by 20
De Masi, R., & Orlando, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137373 · Cited by 20
Palomo, A. G., Blanco, R., Pérez, X. E., Blanco, D., Gabri, M. R., León, K., & Carr, A. (2016) · Clinical & Experimental Metastasis · doi:10.1007/s10585-016-9811-0 · Cited by 19
“Differential association between EGFR signaling pathway and GM3 ganglioside expression has been reported [10–13].”
BackgroundCell Adhesion Molecules as Modulators of the Epidermal Growth Factor Receptor
Kozlova, I., & Sytnyk, V. (2024) · Cells · doi:10.3390/cells13221919 · Cited by 24
“EGFR forms a complex with β 1 and α V β 3 integrins at the cell surface of ECV304 cells, EGFR-transfected NIH-3T3 fibroblasts, and human keratinocyte-derived SCC12 cells [73–75 , 81] and with α 5 β 1 integrin in A2780 cells [ 82 ].”
InfluentialRenal distribution of ganglioside GM3 in rat models of types 1 and 2 diabetes
Novak, A., Mužinić, N. R., Čulić, V. Č., Božić, J., Kurir, T. T., Ferhatović, L., Puljak, L., & Markotić, A. (2013) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-013-0249-4 · Cited by 19
“It has been a widely reported important role of GM3 in cell growth regulation [40, 43], T cell activation [14], signal transduction [4], and insulin signaling [20, 21, 38].”
Noguchi, M., Suzuki, T., Kabayama, K., Takahashi, H., Chiba, H., Shiratori, M., Abe, S., Watanabe, A., Satoh, M., Hasegawa, T., et al. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00578.x · Cited by 18
Choi, H., Chung, T., Kim, S. J., Cho, S. Y., Lee, Y., Lee, Y., Ko, J. H., & Kim, C. (2008) · Glycobiology · doi:10.1093/glycob/cwn016 · Cited by 18
“…sialidase gene transfection enhances the activity of EGFR associated with the induction of cell survival, spreading and migration in squamous carcinoma, and ovarial epidermoid carcinoma cells, indicating the activation of EGFR as a result of decreased GM3 (Meuillet et al. 1999; Wang et al. 2003).”
BackgroundInfluentialChigwechokha, P. K., Komatsu, M., Itakura, T., & Shiozaki, K. (2014) · Gene · doi:10.1016/j.gene.2014.09.029 · Cited by 17
Lu, J., Wang, X., Fu, Z., Gao, L., Mannam, H., Xiang, Y., Joo, Y. Y., Zeng, J., Wang, D., & Paller, A. S. (2023) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2023.05.015 · Cited by 16
Self-citationFu, R., Jordan, P., Engels, Z., Weihs, J. A., Mürle, J., Chi, H., de Lara, S. B., Helm, B., Klöhn, M., Hu, J., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-61071-y · Cited by 23
Dookwah, M., Wagner, S. K., Ishihara, M., Yu, S., Ulrichs, H., Kulik, M. J., Zeltner, N., Dalton, S., Strauss, K. A., Aoki, K., et al. (2023) · Human Molecular Genetics · doi:10.1093/hmg/ddad146 · Cited by 15
Huang, S., Abutaleb, K., & Mishra, S. (2024) · Biomolecules · doi:10.3390/biom14101265 · Cited by 13
“For example, the GM3 ganglioside can inhibit the autophosphorylation of the epidermal growth factor receptor (EGFR), thereby disrupting signaling pathways crucial for cancer progression [12].”
BackgroundOxygenation alters ganglioside expression in rat liver following partial hepatectomy
Markotić, A., Čulić, V. Č., Kurir, T. T., Meisen, I., Büntemeyer, H., Perica, V. B., Zemunik, T., Petri, N. M., Mesarić, M., Peter‐Katalinić, J., et al. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.02.139 · Cited by 10
Modulation of Growth Factor Receptors in Membrane Microdomains
Inokuchi, J., & Kabayama, K. (2008) · Trends in Glycoscience and Glycotechnology · doi:10.4052/tigg.20.353 · Cited by 11
Suzuki, K. G. N., Komura, N., & Ando, H. (2023) · Glycoconjugate Journal · doi:10.1007/s10719-023-10116-9 · Cited by 8
Wang, P., Su, X., Wang, Y., Wu, P., Zhang, J., Sato, T., Yamagata, S., & Yamagata, T. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.01963.x · Cited by 8
Re‐Epithelialization of Wounds
Larjava, H., Häkkinen, L., & Koivisto, L. (2012) · Wiley eBooks · doi:10.1002/9781118704509.ch5 · Cited by 9
Receptor Modifications in Glycobiology
Inokuchi, J., & Kabayama, K. (2007) · Elsevier eBooks · doi:10.1016/b978-044451967-2/00071-4 · Cited by 8
Palomo, A. G., Medinilla, A. L., Segatori, V. I., Barroso, M. D. C., Blanco, R., Gabri, M. R., Carr, A., & León, K. (2018) · Oncotarget · doi:10.18632/oncotarget.25290 · Cited by 6
“Dying tumor cells will be a source of NGcGM3 and EGFR together with some strong immune stimulatory signals.”
BackgroundInfluentialAnchored and soluble gangliosides contribute to myelosupportivity of stromal cells
Ziulkoski, A. L., Santos, A. X. S., Andrade, C. M. B., Trindade, V. M. T., Daniotti, J. L., Borojević, R., & Guma, F. T. C. R. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.07.092 · Cited by 5
Interactions Between Caveolin-1 and Sphingolipids, and Their Functional Relevance
Sonnino, S., Prioni, S., Chigorno, V., & Prinetti, A. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-3381-1_8 · Cited by 5
Avissar, N. E., Toia, L. M., & Sax, H. C. (2005) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607105029005322 · Cited by 4
Jastrząb, P., Car, H., & Wielgat, P. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.117921 · Cited by 4
Kim, J.-W., Park, H., Jung, J., Yang, S., Kim, M., Kim, I., Jega, H.-G., & Koo, D. (2018) · Journal of Animal Reproduciton and Biotechnology · doi:10.12750/jet.2018.33.4.287 · Cited by 3
Kurir, T. T., Čulić, V. Č., Zemunik, T., Grković, I., Terzić, J., Padovan, M., Petri, N. M., & Markotić, A. (2007) · Acta Histochemica · doi:10.1016/j.acthis.2007.09.001 · Cited by 3
Membrane Regulation of EGFR Signaling by Gangliosides
Wang, X., & Paller, A. S. (2009) · The Open Dermatology Journal · doi:10.2174/1874372200903010159 · Cited by 3
“Activation of PKC- triggers EGFR Thr 654 phosphorylation, induces the internalization of EGFR, and makes EGFR unavailable for ligand binding-induced activation or crosstalk with other membrane molecules, such as integrin [36, 44].”
BackgroundSelf-citationGanglioside profiling in neuroblastoma
Singh, M. P., Choudhary, M., Singh, A. P., Datt, N., Thakur, N., Ramarao, N., Ponnuru, V. S., Grover, M., Shukla, S. K., & Kumar, A. (2025) · Clinica Chimica Acta · doi:10.1016/j.cca.2025.120568 · Cited by 1
Shao, W., Yu, C., Xu, R., Rong, X., & Yang, A. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1664915 · Cited by 2
The Role of Gangliosides in Renal Cell Carcinoma
Shaheen, P. E., Bukowski, R. M., & Finke, J. H. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-332-5_22
“Endogenous depletion of this ganglioside by stable gene transfection on the other hand resulted in increased stimulation of EGFR and MAP kinase signaling ( 45 ).”
BackgroundJia, F. (2013) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3fj29n0d
Gangliosides generalities and role in cancer therapies
Pasquel-Dávila, D. S., Yanez-Vaca, S. A., Espinosa-Hidalgo, N. D., & Buenaventura, E. G. C. (2019) · Bionatura · doi:10.21931/rb/cs/2019.02.01.28 · Cited by 1
Iwabuchi, K., & Prinetti, A. (2022) · Glycoconjugate Journal · doi:10.1007/s10719-022-10090-8
“It appears likely that GM3 affects EGFR signaling through a distinct molecular mechanism for modulation of EGFR/caveolin-1 association, and that GM3 negatively regulates cross-talk between EGFR and integrin receptor signaling [32].”
BackgroundDeciphering the role of glycolipids as emerging therapeutic targets in EMT-driven cancer progression
Mukherjee, A., Paul, S., Datta, C., & Bhattacharjee, A. (2026) · Discover Oncology · doi:10.1007/s12672-026-04819-2 · Cited by 1
“Evidences have found GSL specifically ganglioside GM3 may predominantly act as suppressor in EMT by interacting and preventing the auto-phosphorylation of EGFR, one of the major drivers in EMT transition [47, 48].”
Cis glycan–glycan interactions organize membrane nanodomains that tune receptor signaling
Suzuki, K. G. N., Komura, N., Asano, S., Takahashi, M., Yamaguchi, E., Yamazaki, A., Imamura, A., Shibutani, S., Chadda, R., Tsunoyama, T. A., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-76857-x
“EGFR is broadly detected in epithelial lineages 63 , whereas GM3 is widely distributed in mammalian cells and tissues 64 and has been described as the predominant ganglioside of epithelial cells 65 .”
NEU3 at the plasma membrane: context-dependent ganglioside remodeling in health and disease
Cirillo, F., Rota, P., Anastasia, L., & Piccoli, M. (2026) · Journal of Lipid Research · doi:10.1016/j.jlr.2026.101175
Membrane Perturbation By Bile Acids and Their Potential Role in Signaling
Jean‐Louis, S. (2005) · UA Campus Repository (The University of Arizona)
Metadata
- Authors
- Wang, X.-Q., Sun, P., & Paller, A. S.
- Affiliations
- Northwestern University (US)
- Corresponding author
- Paller, Amy S.
- ORCID
- Paller, Amy S.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-12
- Volume
- 278
- Issue
- 49
- Pages
- 48770-48778
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2065871961
- Cited by
- 87
- References
- 69
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 2 · 2023: 3 · 2022: 4 · 2021: 2 · 2020: 1 · 2019: 1 · 2018: 4 · 2017: 1 · 2016: 2 · 2015: 2 · 2014: 5 · 2013: 7 · 2012: 6
- FWCI
- 2.39
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6139 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01 AR44619, R01AR044619)
- Topics
- Health Sciences › Medicine › Oncology › HER2/EGFR in Cancer Research
- Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- GM3 ganglioside, epidermal growth factor receptor, beta1 integrin, ligand-independent receptor activation, tyrosine phosphorylation, Src family kinases, phosphatidylinositol 3-kinase, cell proliferation, squamous cell carcinoma, MAPK signaling, focal adhesion kinase
- MeSH terms
- Cell Line, G(M3) Ganglioside, Humans, Phosphorylation, Protein-Tyrosine Kinases, Tyrosine, Signal Transduction, Integrin beta1, src-Family Kinases, Phosphatidylinositol 3-Kinases, Receptor Cross-Talk, Mitogen-Activated Protein Kinases, Focal Adhesion Protein-Tyrosine Kinases, Focal Adhesion Kinase 1, ErbB Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.